Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
语言: | 英语 |
出版: |
2008
|
在线阅读: | https://doi.org/10.2337/db07-1476 |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
成为第一个发表评论!